Clinical Trial Update: Drug Penetration Into Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports on the penetration of Debio 1450 into bone after repeated oral dosing in patients undergoing hip replacement surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Diseases
• Infectious Diseases

Drugs mentioned

• Debio 1450

Snippet

Sponsor: Debiopharm International SA | Conditions: Bone Diseases, Infectious | Phase 1 | Status: COMPLETED